
Oxytetracycline HCl, Hydrocortisone Acetate, Polymyxin B Sulfate (Ear/Eye Drops/Ointment), Hearing and vestibular disorders, Regorafenib, Stivarga, Hyperammonaemia, hyperammonaemic encephalopathy

Oxytetracycline HCl, Hydrocortisone Acetate, Polymyxin B Sulfate (Ear/Eye Drops/Ointment), Hearing and vestibular disorders, Regorafenib, Stivarga, Hyperammonaemia, hyperammonaemic encephalopathy

Teysuno (tegafur, gimeracil,and oteracil), Hyperammonaemia

Mogamulizumab, Colitis

Afatinib, Lenvatinib, Lenvima, Kisplyx

Major global health organizations, including the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the World Health Organization (WHO), do not recognize autism as a known adverse drug reaction (ADR) of paracetamol. Review of Studies The controversy largely stems from observational studies (not clinical trials) that suggested a potential association between prenatal exposure to paracetamol and a slightly...
Advancing Medication Safety Through Knowledge and Vigilance